Adrenergic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Adrenergic drugs, also called as sympathomimetic drugs, are the medication used to stimulate the sympathetic nervous system located in several parts of the body such as the chest and lower back region of the spinal cord. These drugs stimulate the chemical messenger epinephrine and norepinephrine from the adrenal gland, or replicate the action of these chemical messengers. These drugs are utilized to increase the breathing rate, heartbeat, sweating, urine flow, and prevent bleeding. Adrenergic drugs have diverse applications in the treatment of several life-threatening conditions such as chronic obstructive pulmonary diseases (COPD), asthma, cardiac arrest, shock, and allergic reactions. Bronchodilators, vasopressors, and cardiac stimulators are the three major types of adrenergic drugs, with each having different applications in treating a variety of disease indications.
The global adrenergic drugs market is projected to driven by the high prevalence and rising incidences of chronic obstructive pulmonary diseases (COPD), asthma, and cardiac arrest worldwide. According to a WHO estimate, more than 251 million people worldwide were affected by chronic obstructive pulmonary disease in 2016. According to the American Heart Association (AHA), each year, more than 350,000 cases of cardiac arrest are reported at hospital set ups. Moreover, new product development, increasing applications of these drugs for a variety of disease indications and approvals by regulatory authorities are likely to fuel the adrenergic drugs market during the forecast period. Moreover, new product developments and large number of clinical pipeline products represents the business development opportunity in near future. However, the side effects of these drugs such as irregular heartbeat, high blood pressure, chest pain and other such as nervousness, hallucinations etc. are projected to hamper the usage of adrenergic drugs in the near future.
The global adrenergic drugs market can be segmented based on drug class, route of administration, disease indication, distribution channel, and region. In terms of drug class, the market can be classified into bronchodilators, vasopressors, catecholamines, and others. Bronchodilators are utilized to open the airway tracts by relaxing the bronchial muscles to enable people with breathing disorders to breathe better. The bronchodilators drug class segment is projected to account for a key share of the global adrenergic drug market by the end of forecast period. Albuterol, formoterol, levalbuterol, olodaterol, and salmeterol are some of the most commonly used bronchodilators. The vasopressors drug class segment is anticipated to expand at a significant growth rate during the forecast period owing to the rising incidence of cardiac arrest worldwide. In terms of route of administration, the global market can be segregated into oral route, intravenous route, and inhalation. In terms of disease indication, the global market can be segmented into asthma, chronic obstructive pulmonary disease (COPD), bronchitis, cardiac arrest, shock, and others. Based on distribution channel, the global adrenergic drug market can be segmented into hospital pharmacy, retail pharmacy, and e-commerce.
In terms of region, the global adrenergic drug market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to hold prominent share of the global adrenergic drug market by the end of 2025. The leading share of these regions is attributed to the high prevalence of COPD, asthma, and cardiac arrest cases in developed countries, well-established healthcare facilities, and favorable medical reimbursement policies. The market in Asia Pacific is expected to expand at a significant growth rate during the forecast period due to a considerable number of people in China and India being diagnosed with asthma and COPD, increasing healthcare expenditure, and rapidly developing healthcare facilities in the region. The market in Latin America and Middle East & Africa is estimated to expand at a moderate pace during the forecast period.
Key players operating in the global adrenergic drugs market include Boehringer Ingelheim GmbH, Merck & Co., Inc, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca plc, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., and Mylan Pharmaceutical Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017